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https://doi.org/10.1016/j.stemcr.2019.01.006SUMMARYIt is generally considered thatmouse embryonic stemcell (ESC) differentiation into blood cells in vitro recapitulates yolk sac (YS) hematopoi-
esis. As such, similar to YS-derived B-progenitors, we demonstrate here that ESC-derived B-progenitors differentiate into B-1 and marginal
zone B cells, but not B-2 cells in immunodeficient mice after transplantation. ESC-derived B-1 cells were maintained in the recipients for
more than 6 months, secreting natural IgM antibodies in vivo. Gene expression profiling displayed a close relationship between ESC- and
YS-derived B-1 progenitors. Because there are no hematopoietic stem cells (HSCs) detectable in our ESC differentiation culture, successful
long-term engraftment of ESC-derived functional B-1 cells supports the presence of HSC-independent B-1 cell development.INTRODUCTION
Hematopoietic stem cells (HSCs) in the adult bone marrow
(BM) provide all types of blood cells throughout life, while
also self-renewing to maintain blood homeostasis. Blood/
marrow stem cell transplantation is the most advanced
method to cure patients suffering from hematological
malignancies and hematopoietic diseases. Consequently,
tremendous effort has been dedicated to establishing a sys-
tem to produce HSCs from pluripotent stem cells (PSCs)
such as embryonic stem cells (ESCs) or inducible PSCs.
Overexpressing the Hoxb4 gene (Kyba et al., 2002; Wang
et al., 2005), teratoma formation in vivo (Amabile et al.,
2013; Suzuki et al., 2013; Tsukada et al., 2017), and direct
reprogramming by introducing multiple transcriptional
factors into endothelial cells (ECs) (Sugimura et al., 2017)
have demonstrated successful engraftment of PSC-derived
hematopoietic cells. Similarly, a recent advance has re-
ported that Hoxb4 expression combined with Delta-like 1
signaling enables mouse ESC-derived hematopoietic pro-
genitor cells (HPCs) to engraft immunodeficient mice
with a functional adaptive immune system (Lu et al.,
2016). While these PSC-derived functional HSCs have
been reported, low chimerism remains a persistent prob-
lem and it is still challenging to produce an HSC in vitro
with equivalent properties of in vivo HSCs without gene
manipulation. Although conventional ESC differentiation
by embryoid body formation or OP9 co-culture produces
erythromyeloid, B and T lymphoid cells, no transplant-
able HSCs are produced (Nakano et al., 1994; Schmitt
et al., 2004; Yoshimoto et al., 2009). In this sense, conven-
tional ESC differentiation reflects HSC-independent hema-572 Stem Cell Reports j Vol. 12 j 572–583 j March 5, 2019 j ª 2019 The Aut
This is an open access article under the CC BY-NC-ND license (http://creativtopoiesis and mimics yolk sac (YS) hematopoiesis before
HSC emergence at the later stage (Irion et al., 2010; Lin
et al., 2014; Yoshimoto, 2015).
There are several waves of hematopoiesis in the YS
before the detection of the first HSCs at embryonic day
11.5 (E11.5) in the aorta-gonado-mesonephros region
that repopulate lethally irradiated adult mice (Hadland
and Yoshimoto, 2017; Lin et al., 2014). These waves
include primitive erythroid cells and primitive macro-
phages at around E7.5 in the YS and definitive (adult)
type erythromyeloid progenitors from E8.5 to E9.5 YS.
These waves have been considered transient, diminishing
after birth. However, recent lineage tracing studies have
revealed the presence of tissue-resident macrophages
that are produced from early YS precursors independently
of HSCs, persist into post-natal life, and are self-main-
tained without replenishment by BM progenitors (Gin-
houx et al., 2010; Gomez Perdiguero et al., 2015; Schulz
et al., 2012). These hematopoietic waves are recently
recognized as HSC-independent hematopoiesis. Similarly,
we and others have reported T and B lymphoid potential
in the YS and/or para-aortic splanchnopleura (P-Sp) re-
gion prior to HSC emergence by co-culture with stromal
cells (Cumano et al., 1996; Godin et al., 1995; Nishikawa
et al., 1998; Yoshimoto et al., 2011, 2012). However, it is
still controversial whether these Tand B cells are produced
independently of HSCs because the co-culture system
also yields transplantable hematopoietic progenitor/
stem cells from as early as E8.0 embryos, which makes
the origin of early lymphoid cells unclear, whether it is
derived from HSC-independent or -dependent precursors
(Cumano et al., 2001; Matsuoka et al., 2001).hor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. ESC-Derived B-Progenitors Engraft in the Immunodeficient Mice and Differentiate into B-1 Cells and MZ B Cells, but Not
B-2 Cells
(A) A schema for the experimental procedure. Mouse ESCs were differentiated on OP9 into Flk1+ mesodermal cells at day 4 or CD41VE-
cadherin (VC)+ endothelial cells at day 5. The Flk1+ cells or VC+ cells were then re-plated on OP9 with IL-7 and Flt3-ligand for differentiation
to B-progenitors. Once AA4.1+CD19+B220+ B-progenitors were obtained at 10–14 days after initiating the co-culture, those B-progenitors
were transplanted into sublethally irradiated NSG neonates or a subject of RNA sequencing.
(legend continued on next page)
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We previously reported that the earliest B cells produced
in vitro from YS/P-Sp at pre-HSC stages are B-1 cells (Yoshi-
moto et al., 2011). B-1 cells are unique innate-like B cells,
residing mainly in the pleural and peritoneal cavities, and
are segregated from conventional adaptive immune B-2
cells (Baumgarth, 2017). Two subtypes of B-1 cells are cate-
gorized; CD5+B-1a cells and CD5B-1b cells. Among three
subsets of B cells (B-1, B-2, and splenic marginal zone
[MZ] B cells), B-1 and a part of MZ B cells are considered
fetal derived. Especially, CD5+B-1a cells are derived exclu-
sively from progenitors in the fetal liver (FL) and neonatal
BM, not from adult HSCs based on the results of transplan-
tation assays (Ghosn et al., 2012; Hardy and Hayakawa,
1991) and a conditional Rag2 knockout mouse model
(Hao and Rajewsky, 2001). Our report demonstrating the
presence of B-1-specific progenitors in the FL in HSC-defi-
cient embryos supports the concept of HSC-independent
lymphopoiesis (Kobayashi et al., 2014). In addition, the ex-
istence of HSC-independent T lymphopoiesis has been
recently reported in a zebrafish model (Tian et al., 2017).
Thus, based on our prior results above, we hypothesized
that B cells derived from ESCs are also B-1 cells and HSC in-
dependent. To test this hypothesis, we induced mouse
ESCs on OP9 stromal cells into B-progenitors and trans-
planted them into sublethally irradiated NOD/SCID/
Il2rgcnull (NSG) neonates. ESC-derived B cells were detected
as peritoneal B-1 cells and splenic MZ B cells in the recip-
ient mice, similar to YS-derived B cells in our previous re-
ports. These B-1 and MZ B cells were maintained in NSG
mice for more than 6 months and secreted natural immu-
noglobulin M (IgM) antibodies in vivo. RNA sequencing
(RNA-seq) analysis displayed similarity between ESC-
derived and YS-derived B-progenitors.
Taken together, our results demonstrate that functional
transplantable B-1 cells can be produced in conventional
ESC culture and support the existence of HSC-independent
B-lymphopoiesis.(B) Left panel: cobblestone formation of ESC-derived B-progenitors
rescence-activated cell sorting (FACS) analysis of the cells forming
phenotype derived from GFP+ ESCs.
(C) ESC-derived cell (CD45.2+) percentages in the lymphocytes gate
transplantation (short term [ST], n = 14) and at 6 months after trans
(D) The percentage of B cell subsets in the donor-derived IgM+ cells in
cells; YS, YS-derived B cells; FL-B pro, FL-derived B-progenitors; BM B
and BM MNCs were transplanted as a control.
(E) The percentage of B-1a and B-1b cells among the B-1 cells in the
(F) The donor cell (CD45.2+) percentages in the lymphocyte-gated p
engraftments of YS-derived B-progenitors, FL and BM MNCs are also s
(G) The percentages of B cell subsets among donor-derived IgM+ cells
6 weeks and 6 months after transplantation. FO, follicular B cells; MZ, m
to separate B cell subsets are depicted in Figure 2 and Table S1.
(H) Summary for differentiation capacity of progenitors that are deri
***p < 0.0001, **p < 0.01.
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Mouse ESC-Derived B-Progenitors Differentiate into
Only B-1 and MZ B Cells In Vivo
We have previously reported that E9 YS and P-Sp in vitro
culture produced AA4.1+CD19+B220+ B-progenitor cells
that differentiate into B-1 cells, but not B-2 cells, in vivo af-
ter adoptive transfer (Yoshimoto et al., 2011). Based on the
fact that ESC differentiation into hematopoietic lineage
in vitro recapitulates YS hematopoiesis, we hypothesized
that B lymphocytes that were produced in the mouse
ESC culture were B-1 cells, as was the case for YS-derived
B-progenitors. AA4.1+CD19+B220+ B-progenitors were
differentiated from ESCs via Flk1+ mesoderm or VE-cad-
herin (VC)+ ECs, forming cobblestone areas on OP9
stromal cells as reported previously (Figures 1A and 1B)
(Yoshimoto et al., 2009). These AA4.1+CD19+B220+ B-pro-
genitors were injected into the peritoneal cavity of suble-
thally irradiated NSG neonates. Fifty mice were trans-
planted and 27 mice were analyzed at 5–8 weeks and 23
mice were analyzed at 6 months after transplantation.
Fourteen out of 27 mice at 5–8 weeks after transplantation
displayed ESC-derived B cells in the peritoneal cavity (Fig-
ures 1C and 2A; Table S1). Those B cells were all B-1 cells,
not B-2 cells. As expected, ESC-derived B cell subsets
were very similar to YS- and FL-derived B cells (Yoshimoto
et al., 2011), but not to BM-derived B-progenitors (Figures
1D, 1E, and 1H). Of note, ESC-derived B-progenitors fail to
differentiate into B-1a cells (Figures 1E and 2A). ESC-
derived MZ B cells and B-1 cells were also detected in the
recipient spleen at 5 weeks after transplantation (Figures
1F and 2B; Table S1). ESC-derived B-2 follicular B (FO) cells
were not detected, again, similar to the results from YS-
derived B cell engraftment (Figures 1G, 1H, and 2B). No
thymus was detected in the recipient mice and nomyeloid
or T cells were detected in the spleen and BM (Figure S1).on OP9 culture. Scale bar, 100 mm. Middle and right panels: fluo-
the cobblestone areas shows AA4.1+CD19+B220dim B-1 progenitor
d population of the recipient peritoneal cells at 5–6 weeks after
plantation (long term [LT], n = 10) are depicted.
the peritoneal cavity of recipient mice is shown. ES, ESC-derived B
-pro, adult BM-derived B-progenitors. FL mononuclear cells (MNCs)
recipient peritoneal cavity.
opulation of the recipient spleen (n = 24 for both ST and LT). The
hown as controls.
in the recipient spleen are shown. The data were collected from 5 to
arginal zone B cells. Representative FACS plots and surface markers
ved from ESC, YS, FL, and BM. P-, peritoneal; S-, spleen.
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Figure 2. Flow Cytometric Analysis of the Recipient Peritoneal Cells and Spleen
Representative FACS plots for the analysis of peritoneal cells (PerC) (A) and spleen cells (SPL) (B) in the recipient mice transplanted with
ESC-derived B-progenitors (AA4.1+CD19+B220+ cells) at 5–6 weeks after transplantation (n = 14) are depicted. Upper panels in (A and B)
show FACS plots from non-transplanted C57BL/6 mice. Lower panels in (A and B) show ESC-derived B cell subsets in the PerC (A) and spleen
(B) of the transplanted mice, respectively. Surface markers for each B cell subset are listed in Table S1. FO, follicular B cells; MZ, marginal
zone B cells.Thus, only B-1 and MZ B cells were differentiated from
ESC-derived B-progenitors in the recipient mice.
ESC-Derived B Cells Display Long-Term Engraftment
in the Peritoneal Cavity and Spleen
An important characteristic of B-1 cells is self-replenishing
ability.We detected ESC-derived B-1 cell engraftment more
than 6 months in 10 out of 23 transplanted mice without
engraftment of other lineages (Figures 1C and 3A). ESC-
derived B-1 and MZ B cells were also detected in the
recipient spleen (Figures 1F, 1G, and 3A). Fat-associated
lymphoid clusters (FALCs) have recently been reported as
a niche for B-1 cells (Benezech et al., 2015; Moro et al.,
2010). Fat tissues were isolated from the recipient perito-
neal cavity and stained with anti-IgM antibodies. While
non-transplanted NSG mice did not show any IgM+ cells,
transplanted NSG mice showed a few, but large, IgM+
clusters in the peritoneal fat tissues (Figure 3B). We alsoexamined ESC-derived IgM+ cells in the recipient spleen.
IgM+IgD B-1/MZ B cells were confirmed as clusters in
the recipient spleen (Figure 3C) although a normal follic-
ular structure was not seen due to lack of T and B-2 cells.
Thus, ESC-derived B-progenitors differentiate into B-1
cells in the peritoneal cavity and MZ B cells in the spleen
in the recipient mice and are maintained for more than
6 months.
ESC-Derived B-1 Cells Secrete Natural Antibodies
In Vivo
To confirm the natural antibody production ability of ESC-
derived B-1 cells, we isolated ESC-derived B-1 cells en-
grafted in the recipient peritoneal cavity and performed
ELISpot assays. When the same number of B-1 cells were
plated in the plate coated with anti-mouse IgM antibodies,
a similar number of spots were observed in ESC-derived B-1
cells and control C57 BL/6 B-1 cells, but not in B-2 cellsStem Cell Reports j Vol. 12 j 572–583 j March 5, 2019 575
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Figure 3. ESC-Derived B-1 Cells Are Functional to Secrete Natural Antibodies and Maintained in the Recipient Mice
(A) ESC-derived B cell subsets in the peritoneal cavity and spleen from the recipient NSG mice at 6 months after transplantation with
AA4.1+CD19+B220+ B-progenitors. Representative FACS plots are depicted among ten transplanted mice. FO, follicular B cells; MZ, marginal
zone B cells.
(B) Immunostaining of FALCs in non-transplanted C57BL/6 (B6) mice (control) and the recipient mice after phosphorylcholine (PC)
stimulation (n = 3). Red, anti-IgM antibody; blue, DAPI. Scale bars, 100 mm (upper panel) and 200 mm (lower panel).
(C) Immunostaining of spleen in non-transplanted B6 mice (control) and the recipient mice after PC stimulation (n = 3). Green, anti-IgD
antibody; red, anti-IgM antibody; blue, DAPI. Scale bar, 100 mm.
(D) ELISpot assays against anti-PC IgM using 1,000 ESC-derived B-1 cells harvested from the peritoneal cavity of transplanted mice, and
1,000 B-1 and B-2 cells harvested from the B6 peritoneal cavity (n = 3 for each group).
(E) Concentrations of serum IgM from non-transplanted NSG with or without PC stimulation, NSG mice transplanted with ESC- or YS-derived
B-progenitors, and non-treated B6 mice are depicted. All transplanted mice were stimulated with PC before collecting the serum (n = 3 for
each group).
**p < 0.01.
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(Figure 3D). Phosphorylcholine was injected into the mice
transplanted with ESC-derived B cells and the serum IgM
was measured by enzyme-linked immunosorbent assay
(ELISA) assays (Figure 3E). The control mice transplanted
with YS-derived B cells displayed similar levels of serum
IgM to non-transplanted C57BL/6 mice. The recipient
NSG mice transplanted with ESC-derived B cells showed
elevated IgM levels compared with non-transplanted NSG
mice, although less than non-transplanted C57BL/6 serum
IgM or YS-derived serum IgM. The difference in IgM level
between mice transplanted with ESC- and YS-derived B
cells might depend on the cell numbers engrafted in the
host mice. Thus, ESC-derived B-1 cells are functional IgM-
secreting cells in vivo.
Gene Expression Profile of ESC-Derived B-Progenitors
Is Similar to that of YS- and FL-Derived B-1 Progenitors
Wecompared gene expression profiles amongESC-, YS-, and
FL-derived B-1 progenitors and BM-derived B-2 progenitors
to evaluate molecular similarities (Figure 4A). Principal-
component analysis showed that ESC-derived B-progenitors
are molecularly closer to YS- and FL-derived B-1 progenitors
rather than BM-derived B-2 progenitors, as expected (Fig-
ure 4B). However, there were 1,759 genes differentially ex-
pressed between ESC-derived and YS-derived B-1 progeni-
tors (p < 0.05, false discovery rate [FDR] < 0.05, >2-fold).
Among them, 715 genes were upregulated and 1,044
genes were downregulated in ESC-derived B-progenitors
compared with YS-derived B-progenitors. On the other
hand, 4,805 genes were differentially expressed between
ESC- and BM-derived B-progenitors (2,479 genes were upre-
gulated, and 2,326 genes were downregulated in ESC-
derived B-progenitors, p < 0.05, FDR < 0.05, >2-fold).
Careful evaluation of the transcription factors important
for B cell development revealed that ESC-derived B-progen-
itors were similar to those of YS- or FL-derived B-progeni-
tors (Figure 4C). Since FL-derived B-progenitors include
some cells with B-2 potential, expression was at times
similar to BM-derived B cells, depending on the genes.
Lmo2, Spi1 (PU.1), Pax5, Ebf1, and Ikzf1 were expressed
higher in BM-derived B-progenitors than ESC-, YS-, and
FL-derived B-1 progenitors, while Rag2 and Bcl11awere ex-
pressed higher in the ESC-, YS-, and FL-derived B-progeni-
tors (Figure 4C). Expression patterns of chemokine recep-
tors showed a distinct difference between YS/FL-derived
B-1 progenitors and BM-derived B-2 progenitors, and those
chemokine receptors appeared to be silent in ESC-derived
B-progenitors (Figure 4D). Among them, Ccr7 and Cxcr5
were expressed differently between ESC-derived and YS/
FL-derived B-progenitors. CXCR5 is an important homing
receptor for B-1 cells that promotes retention in the perito-
neal cavity (Hopken et al., 2004), thus this difference could
account for the lower efficiency of ESC-derived B cellengraftment in the recipient mice. Expression of some
cytokine receptors was also reduced in the ESC-derived
B-progenitors (Figure 4E). We also looked into genes
involved in epigenetic modification (Figure 4F). We
confirmed that ESC-derived B-progenitors showed lower
expression of Bmi1 and Rnf2 (Ring1B), an important
component of polycomb repressive complex 1. We per-
formed gene ontogeny (GO) enrichment analysis between
ESC- and YS-derived B-progenitors and identified the top
10 categories of upregulated genes in YS-derived B-progen-
itors (Figure 4G) and in ESC-progenitors (Figure 4H).While
MHC protein complex and interferon-g signaling path-
ways were upregulated in the YS-derived B-1 progenitors,
some mesodermal developmental signatures were still up-
regulated in the ESC-derived B-1 progenitors. Taken
together, ESC-derived B-1 progenitors may not be fully
developed, although B cell transcription factors are similar
between YS- and ESC-derived B-1 progenitors. Nonethe-
less, engrafted ESC-derived B-1 cells were immunologically
functional; thus, some ESC-derived B-progenitors might be
selected in vivo or these differences may reflect the lack of
B-1a cells from ESC-derived B-1 progenitors.
Bmi1 Overexpression Improved ESC-Derived B-1 Cell
Engraftment
Since Bmi1 expression was reduced in ESC-derived B-pro-
genitors (Figure 4F) and Bmi1 overexpression is reported
to increase the self-renewal capacity of HSCs and self-re-
newing YS-derived erythroid progenitor cells (Iwama
et al., 2004; Kim et al., 2015), we hypothesized that overex-
pression of Bmi1might improve ESC-derived B cell engraft-
ment. qPCR showed less Bmi1 expression in ESC-derived
B-progenitors compared with YS-derived B-progenitors
(Figure 5A). Therefore, we overexpressed Bmi1 in ESCs by
retrovirus, differentiated them into B-progenitors on
OP9, and transplanted AA4.1+CD19+B220+ B-progenitors
into sublethally irradiated NSG neonates as described
above. Elevated Bmi1 expression was confirmed by qPCR
(Figure 5A). In the recipient peritoneal cavity, Bmi1-overex-
pressing B cells demonstrated significantly better en-
graftment at 4–5 weeks (Figure 5B, n = 8, average donor
26.6% ± 21.3%, p = 0.01), and at 4 months after transplan-
tation (Figure 5C, n = 7, average donor 21.4% ± 16%,
p < 0.05) compared to parent ESC-derived B cells (n = 5,
0.73% ± 0.58% at 5 weeks, n = 3, 4.3% ± 2.1% at 4months).
Of note, despite improved engraftment, ESC-derived B-1a
cells were not detected (Figure 5D).
We also examined CXCR5 expression in differentiated
ESC-derived IgM+ cells on OP9 culture because CXCR5
is an essential chemokine receptor expressed in the perito-
neal B-1 cells and Cxcr5 deletion induced B-1 cell loss in
the peritoneal cavity (Hopken et al., 2004). We confirmed
CXCR5 expression in B-1 cells of non-transplantedStem Cell Reports j Vol. 12 j 572–583 j March 5, 2019 577
Figure 4. The Gene Expression Profile of ESC-Derived B-1 Cells Is Similar to that of YS- and FL-Derived B-1 Cells
(A) An experimental procedure.
(B) Principal-component analysis of RNA sequencing profiles among ESC-, YS-, FL-, and BM-derived B-progenitors.
(C–F) Heatmap analysis among ESC-, YS-, FL-, and BM-derived B-progenitors for B cell-related transcription factors (C), chemokine re-
ceptors (D), cytokine receptors (E), and epigenetic regulatory genes (F).
(G and H) The top 10 categories of upregulated genes in YS-derived B-progenitors (G) and ESC-progenitors (H) between these two
populations by gene ontology enrichment analysis are listed. B-pro, B-progenitors
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Figure 5. Overexpressing Bmi1 Improved ESC-Derived B-1 Cell Engraftment
(A–C) Bmi1 expression in B cells produced in vitro from YS, CCE (ES), parent ES, and Bmi1-expressing ESCs (A). The percentages of donor-
derived B cells in the peritoneal cavity (lymphocyte-gated) of the recipient mice at 5 weeks (B) and 4months (C) after transplantation with
AA4.1+CD19+B220+ B-progenitors derived from regular ESCs (ES total, left), parent ESCs (middle), and Bmi1-expressing-ESCs (right) are
shown.
(D) B cell subsets derived from Bmi1-expressing ESCs engrafted in the recipient peritoneal cavity.
(E) CXCR5 expression (pink) in non-transplanted B6 B-1 cells and engrafted ES-derived B-1 cells. Blue population is fluorescent-minus-one
for CXCR5 as a negative control.
(F) CXCR5 expression (pink) in IgM+ B cells differentiated from YS, parent ESCs, and Bmi1-ESCs on OP9 culture. Blue is CXCR5-negative
population. Representative histograms are depicted (n = 3 for each group).
**p < 0.01, *p < 0.05.C57BL/6 mice and ESC-derived B-1 cells engrafted in NSG
mice (Figure 5E). However, in in vitro differentiation on
OP9, IgM+ cells from parent ESCs was not efficiently pro-
duced and showed less CXCR5 expression, while YS and
Bmi1-ESCs differentiated into CXCR5-expressing IgM+
cells at 3 weeks after differentiation (Figure 5F). These re-
sults suggested that the differentiation efficiency into
CXCR5+IgM+ cells may be a key for ESC-derived B-progen-
itors to engraft in the recipient peritoneal cavity. Further
studies have to be done to enhance the engraftment of
ESC-derived B-progenitors.DISCUSSION
We demonstrated that all B-progenitors produced from
mouse ESCs differentiate into only B-1 and MZ B cells in
recipient mice, similar to YS-derived B-progenitors (Fig-
ure 1H). Although ESC-derived B-1 cells are functional in
natural antibody secretion and self-replenishing ability,they differentiate to mostly B-1b cells, not to B-1a cells,
while almost half of YS-derived B-progenitors differentiate
into B-1a cells in vivo (Figure 1E) (Yoshimoto et al., 2011).
This may reflect the difference of gene expression between
ESC- and YS-derived B-progenitors. Although ESC-derived
B-progenitors are molecularly more similar to YS-derived
B-progenitors than BM B-2 progenitors, there were still
1,759 genes differentially expressed between them. Potoc-
nik et al. (1997) have reported B cell reconstitution by
in vitro differentiated mouse ESCs, including both B-1 and
transient B-2 cells. While B-1a cells were dominantly repo-
pulated in their report, our ESC-derived cells repopulated
only B-1b cells and not B-2 cells. This difference may be
due to dissimilarity in culture conditions such as 3D
embryoid body formation versus 2D OP9 co-culture. In
both cases, however, HSCs that could sustain B-2 cell pro-
duction were not detected.
We have previously shown that mouse testis-derived
PSCs differentiate into erythromyeloid progenitors, and
B and T cells in vitro culture, but found very limitedStem Cell Reports j Vol. 12 j 572–583 j March 5, 2019 579
PSC-derived HPC engraftment in the recipient BM and
spleen, detectable by PCR (Yoshimoto et al., 2009). Pearson
et al. (2015) have reported better engraftment of ESC-
derived hematopoietic cells after serum-free differentiation
culture. However, despite T cell differentiation potential
in vitro, T cell engraftment was not shown and B cell
engraftment was limited to the spleen. They indicated
that the engrafted B cells in the recipient spleen were not
B-1 cells because they lacked expression of CD5 and
CD11b. However, CD11b is only expressed in peritoneal
B-1 cells, not in splenic B-1 cells. Furthermore, CD5 expres-
sion is limited to B-1a cells. Since they did not show any B
cell engraftment in the peripheral blood (which is consid-
ered to represent the B-2 cell population), it is very likely
that the ESC-derived B cells engrafted in the recipient
spleen were MZ or B-1 cells, consistent with our results.
Lu et al. (2016) have reported repopulation of functional
adaptive immune T and B cells by engineered mouse ESCs,
which was produced by inducing Notch signaling and
Hoxb4 overexpression. In their control, conventional ESC
differentiation on OP9 (without Notch signaling) pro-
duced only B-1b cells, not B-2 cells, supporting our results.
Notch signaling seems to have induced functional adaptive
B-2 cells via HSCs in their system, although their secondary
transplantation of engineered HSCs displayed T cell domi-
nant engraftment. This result suggests that sustained B-2
potential always accompanies HSC potential, different
from B-1 cells that can be produced by early HSC-indepen-
dent progenitors. Although lymphoid potential has been
used as an indicator of ‘‘definitive hematopoiesis’’ in the
early mouse embryo or ESC differentiation system (Cu-
mano et al., 1996; Kennedy et al., 2012), it is important
to reconsider the definition of definitive hematopoiesis,
because some T and B-1 lymphoid progenitors can be pro-
duced in the absence of HSCs (Chen et al., 2011; Kobayashi
et al., 2014; Tian et al., 2017). In this sense, sustained B-2
cell production may be a more accurate indicator of HSC
activity. Therefore, understanding how B-2 potential is ob-
tained in ESC-derived HPCs would represent an important
area of future investigation.
RNA-seq results also support the similarity between ESC-
and YS-derived B-1 progenitors. Bmi1 expression, known as
an important gene for self-renewal ability in stem cells, was
reduced in ESC-derived B cells compared with YS-derived B
cells, and Bmi1 overexpression improved the engraftment
of ESC-derived B cells in the recipient mice. Our result is
similar to the report that inducing Bmi1 into adult BM
erythroblasts enhanced self-renewal ability extensively
(Kim et al., 2015). Thus, Bmi1 may also play a role in the
self-renewal ability of B-1 cells.
Of note, there was a variation of engraftment efficiency
among B cells derived from regular ESCs (Figures 1C, 5B,
and 5C ES total). Since B-progenitors differentiate into580 Stem Cell Reports j Vol. 12 j 572–583 j March 5, 2019mature IgM+ cells by interacting stromal cells and cyto-
kines in the BM and spleen, the differentiation capacity
and characteristics of each ESC line could be important fac-
tors for the engraftment, and Bmi1-overexpression may
have helped this differentiation process as was seen
in vitro experiments (Figure 5F).
The clinical importance of human B-1 cells has attracted
attention based on themethods to isolate the human coun-
terpart of mouse B-1 cells (Griffin et al., 2011; Griffin and
Rothstein, 2011). Since BM HSCs do not reconstitute B-1a
cells, patients after BM transplantation may lack B-1 cells
if human B-1 cells have similar characteristics with mouse
B-1 cells. Indeed, it has been reported that patients who
develop graft versus host disease following stem cell trans-
plantation are at high risk for developing sepsis from
encapsulated bacteria, associatedwith deficiency of human
B-1-like cells that normally produce natural antibodies to
these bacteria (Moins-Teisserenc et al., 2013). Therefore,
PSC-derived B-1 cells could theoretically be an important
source of cell therapy for these patients in the future.
In summary, our data indicate the successful engraft-
ment of ESC-derived functional B-1 cells without gene
modifications, supporting the presence of HSC-indepen-
dent lymphopoiesis and suggesting possible unique appli-
cations for cell therapy in the future.EXPERIMENTAL PROCEDURES
Mice
NSGmice (CD45.1) and C57BL/6 mice (CD45.2) were maintained
at the Indiana University Laboratory Animal Resource Center and
the Center for Laboratory AnimalMedicine andCare at Institute of
Molecular Medicine, University of Texas Health Science Center at
Houston (UTHealth). All animal experiments were conducted
according to the Guidelines for the Care and Use of Laboratory
Animals under the guidance of Institutional Animal Care and
Use Committees at Indiana University School of Medicine and
for the Animal Welfare Committee at UTHealth at Houston.Flow Cytometry and Magnetic-Activated Cell Sorting
Different fluorochrome-conjugated following antibodies (all pur-
chased from eBioscience) were used for the flow cytometry analysis
and sorting: anti-mouse Flk1 (clone Avas12a1), CD144 (11D4.1),
CD19 (eBio1D3), B220 (RA3-6B2), AA4.1 (AA4.1), IgM (11/41),
CD23 (B3B4), CD11b (M1/70), CD5 (53-7.3), CD45.1 (A20),
CD45.2 (104), CD44 (1M7), CD41 (eBioMWReg30), CD25
(PC61), Thy1.2 (53-2.1), CD3 (145-2C11). Propidium iodide (PI)
(Sigma-Aldrich) was used for live cell gating. Stained cells were
analyzed or sorted on LSRII, FACSCantoII, or FACSAria instrument
(BD). Flow cytometry data were analyzed in FlowJo software.
For magnetic-activated cell sorting, CD19+ cells were separated
following the manufacturer’s instructions using anti-mouse CD19
antibody and anti-Rat IgG MicroBeads (Miltenyi Biotech). The
purityof sortedCD19+cellswas>95%,confirmedbyflowcytometry.
For BMB-progenitor isolation, IgMAA4.1+CD19+B220+ B-2 pro-
genitors were sorted on FACSAria.
OP9 Cells and ESCs
OP9 stromal cells were provided by Dr. Toru Nakano at Osaka Uni-
versity. ESC lines such as D3, D4, and E14 were kindly provided by
Dr. Toshio Heike (retired from Kyoto University). OP9 and ESCs
were maintained as described previously (Yoshimoto et al., 2009).
B Cell Differentiation and Transplantation
B cells were differentiated from ESCs as described previously (Yosh-
imoto et al., 2009). In brief, day 4 Flk1+ or day 5 VC+ cells of ESC
differentiation culture were sorted and re-plated on fresh OP9
monolayers in 6-well culture plates at a density of 3,000–5,000
cells/well and were cultured for an additional 10–14 days in induc-
tion medium with 10 ng/mL interleukin-7 (IL-7) and Flt3-ligand
(PeproTech).
B cells were differentiated from E9.5 YS as described previously
(Yoshimoto et al., 2011).
To obtain FL- and BM-derived B cells, CD19+ B-progenitors from
E14.5 FL or CD19+B220+ B-progenitors from adult BM were sorted
and cultured onOP9 for 6 dayswith 10 ng/mL IL-7 and Flt3-ligand.
After cobblestone-like B cell colonies were formed in the culture,
the cells were collected. AA4.1+CD19+B220+ cells were then sorted
by FACSAria (BectonDickinson) andwere used for downstream ex-
periments or kept in liquid nitrogen as cell pellets for RNA-seq.
For cell transplantation, donor cells were re-suspended in 25 mL
PBS and were injected into the peritoneal cavity of sublethally
(150 rad) irradiated NSG neonates (1–3 days old). At different
time points after transplantation, the peritoneal, spleen or BM cells
were collected and donor cell types were examined by flow
cytometry.
Images and Confocal Microscopy
Pictures of cell culture were taken on a Leica DM IL microscope
with a SPOT RT3 camera (Spot Imaging). For confocal microscopy
images of FALCs, recipient NSG were euthanized, and omentum
and mesenteric fat tissues were dissected. The samples were pre-
pared as described previously (Benezech et al., 2015) and stained
with 1:200 Alexa Fluor 555-conjugated anti-mouse IgM antibody
(SouthernBiotech). Confocal images were taken using an Olympus
II microscope with UApoN340 203/0.7W objectives (Olympus).
ImageJ software was used to adjust and output the images.
Natural Antigen Immunization and ELISA
To measure the serum IgM concentration after natural antigen
challenge, mice were immunized by intraperitoneal injection of
200 mL 0.25 mg/mL phosphorylcholine conjugated to keyhole
limpet hemocyanin (PC-KLH). After 10 days, the mice were
euthanized and blood serum was used for IgM ELISA assay using
eBioscience Mouse IgM ELISA Ready-SET-Go! Kit according to the
manufacturer’s instructions.
ELISpot
ELISpot assays were performed as described previously (Kobayashi
et al., 2014). In brief, B cells were sorted from the peritoneal cavityor spleen of recipient or control animals by FACSAria (BD Biosci-
ence). The cells were re-suspended in RPMI 1640 medium with
10% fetal bovine serum, 5 3 105 M b-mercaptoethanol, and
10 ng/mL IL-5 (PeproTech) and plated on 96-well plates that were
pre-coated with 10 mg/mL PC-KLH. After 24 h incubation, the cells
werecollectedandre-plated intoeachwellofELISpotMultiscreenHTS
Filter Plates (Millipore) pre-coated with 10 mg/mL anti-mouse IgM
antibody (eBioscience). After 24 h, the wells were incubated with
1:2,000 alkaline phosphate-conjugated goat anti-IgM detection
antibody (SouthernBiotech) and the spots were visualized by
BCIP/NBT-plus substrate (Mabtech). Photos of spots were taken us-
ing aZeiss Stemi SV11microscopewithZeiss AxiocamMrc5 camera.RNA-Seq
Cell pellets of sortedB-progenitorsderived fromESCs, E9.5YS, E14.5
FL, and adult BM were snap-frozen in liquid nitrogen and stored
at 80C before RNA isolation. RNA was isolated using RNeasy
MicroMini Kit (QIAGEN) and submitted to the Center for Medical
Genomics at IUSM for the RNA-seq. Total RNA was first evaluated
for its quantity and quality, using an Agilent Bioanalyzer. Starting
amount of total RNA ranged from 200 to 1,000 ng for library prepa-
ration. Ribosomal RNA was first removed from total RNA using a
standard protocol for the Ribo-Zero Magnetic Gold Kit (Epicentre,
cat. no. MRZG12324/RZG1224). After the depletion of rRNA,
cDNA library preparation included enzymatic fragmentation,
hybridization, and ligation of adaptors, reverse transcription, size
selection, and amplification with barcode primers, following the
Ion Total RNA-Seq Kit v.2 User Guide, Pub. no. 4476286 Rev. E
(Life Technologies). Each resulting barcoded library was quantified
and its quality assessed byAgilent Bioanalyzer andmultiple libraries
pooled inequalmolarity. Eightmicrolitersof100pMpooled libraries
were then applied to Ion Sphere Particles (ISP) template preparation
and amplification using Ion OneTouch 2 (Life Technologies),
followedby ISP loadingontoaPI chipand sequencingon IonProton
semiconductor (Life Technologies). Each PI chip allowed loading
of about 140 million ISP templates, generating approximately
80–100 million usable reads, up to 10–15 Gb.Bioinformatic Analysis
RNA-seq was carried out using a standard RNA-seq protocol by Ion
Proton technology in the Center for Medical Genomics, Indiana
University. The sequencing data were mapped to theMus musculus
mm10 reference genomeusing RNA-seq aligner STAR (v.2.4.2) (Do-
bin et al., 2013). The gene-based expression levels were quantified
with featureCounts (subread v.1.5.0) (Liao et al., 2014) applying
parameters ‘‘-s 1 –Q 10.’’ Read counts were normalized to the total
number of sequencing reads falling into annotated gene regions in
each sample, and further scaled based on a trimmed mean of log
transformed counts per million (CPM) value to correct for the vari-
ability of RNA composition in each sample. The genes with greater
than one read permillionmappable reads (CPM> 1) in at least four
sampleswere kept for gene differential expression analysis with the
R/Bioconductor package edgeR (Robinson et al., 2010). Benjamini
and Hochberg’s algorithm was used to control the FDR. Gene set
enrichment analysis was performed on the C2 curated gene sets
and the C5GOgene sets of theMolecular SignatureDatabase using
the function CAMERA in edgeR (Robinson et al., 2010).Stem Cell Reports j Vol. 12 j 572–583 j March 5, 2019 581
Overexpressing Bmi1 in ESCs
Mouse Bmi1 cDNAwas cloned into pMIPTcG (pMIEG3-IRES-puroR/
T2A/GFP) and the sequencewas confirmed. Subsequently, virus was
produced with Phoenix-Eco producer line by a standard method
(Kobayashi et al., 2017). ESCs were infected with pMIPTcG-Mock
or -Bmi1 virus, followed by selection with puromycin.
Statistics
The unpaired, two-tailed Student’s t test was used for statistical
analysis in this study.
RNA-Seq Accession Number
RNA-seq data are available in the GEO under accession number,
GSE123809.
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